Spencer R. Berthelsen, Director at IONIS PHARMACEUTICALS INC (IONS), sold 8,000 shares at $73.49 ($588K) on 2026-06-15, disclosed to the SEC on 2026-06-16.
Scheduled sale ($588k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| IONS | SELL | 2021-06-25 | $566K | — | Filing → |
| IONS | SELL | 2020-06-25 | $881K | — | Filing → |
| IONS | SELL | 2019-06-26 | $1.9M | — | Filing → |